SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three- and twelve-month periods ended December 31, 2016.
Full Year 2016 and Recent Company Highlights:
Completed an oversubscribed Rights Offering in March 2017 for existing shareholders and raised $20.1 million in gross proceeds;
The Company anticipates a strong first quarter of 2017 with nine Argus® II Retinal Prosthesis System (Argus II) surgeries completed and six additional surgeries scheduled before quarter end;
